This example shows a report table, trial design,
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-78 |
|---|
|
and results data for the in vitro neutral red uptake (NRU) cytotoxicity assay
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-333 |
|---|
|
in example study 123.
| Expand |
|---|
| title | Sample from Report Table |
|---|
|
The following shows example data for study 123 in a report table. This report includes summary statistics (i.e., average, standard deviation, coefficient variation) for each plate and an EC50 | Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-593 |
|---|
|
value for the entire value for the entire assay. In the table below, the light grey shading for plate 1 are values from wells that do not contain the NHK cells. The dark grey shading represents the column and row location within the 96-well plate, and in this example the applicant chose to use these column and row locations to assign their REFID values in the RELREF dataset and GT dataset. For brevity, the datasets in this example are not comprehensive but are intended to demonstrate a range of proper use.
Neutral Red Cytotoxicity Assay Results (Relative Absorbance Data) |
|
|
| Sample ID | Smoke Regime | Replicate Number | Plate Number |
|
| Relative Assay Plate Absorbance Readings |
|
|
|
| Cigarette Smoke Condensate (µg/mL) | SLS (µg/mL) |
| EC50 (µg/ml) | Well Column: | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| Well
Row: | 0 | 10 | 50 | 75 | 100 | 120 | 140 | 160 | 200 | 110 | 200 | 0 |
|
| 030001 | Medium | 1 | 1 | A | 0.046*
| 0.046* | 0.039* | 0.012* | 0.030* | 0.003* | 0.057* | 0.032* | 0.003* | 0.050* | 0.044* | 0.040* |
|
| 030001 | Medium | 1 | 1 | B | 0.048* | 107 | 77.7 | 65.7 | 30.2 | 15.6 | 9.79 | 5.41 | 2.49 | 8.09 | 0.791 | 0.014* |
|
| 030001 | Medium | 1 | 1 | C | 0.005* | 98.6 | 77.4 | 57.7 | 35.8 | 8.09 | 7.36 | 3.22 | 0.791 | 6.38 | 0.061 | 0.050* |
|
| 030001 | Medium | 1 | 1 | D | 0.049* | 94.9 | 81.5 | 38.2 | 31.2 | 7.60 | 5.17 | 3.22 | 0.791 | 5.17 | 0.304 | 0.017* |
|
| 030001 | Medium | 1 | 1 | E | 0.047* | 111 | 78.1 | 64.5 | 32.9 | 8.82 | 5.90 | 2.74 | 1.28 | 10.3 | 0.547 | 0.011* |
|
| 030001 | Medium | 1 | 1 | F | 0.032* | 96.6 | 76.2 | 48.0 | 26.8 | 7.84 | 4.20 | 2.74 | 1.52 | 8.09 | 4.93 | 0.022* |
|
| 030001 | Medium | 1 | 1 | G | 0.044* | 105 | 77.9 | 58.2 | 28.3 | 8.09 | 4.68 | 1.76 | 0.547 | 8.57 | 1.76 | 0.056* |
|
| 030001 | Medium | 1 | 1 | H | 0.056* | 0.013* | 0.040* | 0.008* | 0.013* | 0.002* | 0.029* | 0.018* | 0.006* | 0.016* | 0.024* | 0.046* |
| Average |
| 101 | 78.2 | 54.5 | 29.9 | 9.70 | 6.17 | 3.37 | 1.19 | 8.94 | 1.22 |
|
| Std. Dev. |
| 6 | 2.9 | 9.4 | 3.6 | 2.95 | 2.19 | 1.12 | 0.72 | 2.72 | 1.58 |
|
| Coeff. Var. |
| 5.8 | 3.6 | 17.2 | 11.9 | 30.4 | 35.5 | 33.1 | 61.0 | 30.5 | 129.9 |
|
| *media without cells |
|
|
|
|
|
|
|
|
|
|
|
|
|
| 030001 | Medium | 1 | 2 | A |
| 93.4 | 74.0 | 56.0 | 35.1 | 11.8 | 8.70 | 5.10 | 1.98 | 5.34 | 1.02 |
|
|
| 030001 | Medium | 1 | 2 | B |
| 102 | 75.2 | 53.3 | 35.1 | 11.8 | 7.74 | 5.58 | 3.66 | 5.34 | 1.02 |
|
|
| 030001 | Medium | 1 | 2 | C |
| 107 | 79.0 | 55.0 | 26.5 | 10.1 | 6.06 | 3.66 | 1.74 | 7.02 | 0.780 |
|
|
| 030001 | Medium | 1 | 2 | D |
| 104 | 80.2 | 55.3 | 29.8 | 8.94 | 3.90 | 3.66 | 1.50 | 6.30 | 0.780 |
|
|
| 030001 | Medium | 1 | 2 | E |
| 101 | 75.7 | 54.1 | 26.7 | 4.86 | 4.38 | 1.26 | 1.02 | 6.30 | 1.02 |
|
|
| 030001 | Medium | 1 | 2 | F |
| 110 | 85.7 | 67.7 | 26.0 | 5.34 | 4.62 | 3.42 | 1.50 | 6.30 | 0.540 |
|
|
| 030001 | Medium | 1 | 2 | G |
| 104 | 77.8 | 64.9 | 27.7 | 8.22 | 3.18 | 2.46 | 1.02 | 6.30 | 0.780 |
|
|
| 030001 | Medium | 1 | 2 | H |
| 103 | 71.6 | 58.9 | 25.5 | 9.42 | 4.14 | 3.90 | 1.26 | 4.38 | 0.780 |
|
| Average |
| 103 | 77.4 | 58.1 | 29.0 | 8.82 | 5.34 | 3.63 | 1.71 | 5.91 | 0.840 |
|
| Std. Dev. |
| 5 | 4.4 | 5.3 | 4.0 | 2.63 | 1.97 | 1.37 | 0.86 | 0.83 | 0.170 |
|
| Coeff. Var. |
| 4.6 | 5.6 | 9.2 | 13.6 | 29.8 | 36.9 | 37.6 | 50.0 | 14.1 | 20.2 |
|
| EC50 (µg/ml). Effective concentration at 50% cytotoxicity. (using a specific sigmoidal equation = model). |
|
|
|
|
|
|
|
|
|
|
|
| 123 |
|
| Dataset wrap |
|---|
| Rowcaps |
|---|
| Rows 1-2: | Show 2 records for TSPARMCD = "GLPTYP", using TSSEQ to indicate multiple records, since both GLP types apply for this example study. | | Row | 8| 3: | Shows that | the applicant's | Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-356 |
|---|
|
| this study was conducted as a GLP study. | | Rows 4-5: | Show the study start date and study title. | | Rows 6-7: | Show the version of SEND Implementation Guide and version of Controlled Terminology used in this study. | | Row 8: | Shows the applicant's organization. | | Row 9: | Shows that the applicant's study reference ID is not applicable. | | Rows | 9| 10- | 12| 13: | Show that TSGRPID has been used to link records (name, location, country) related to the test facility (TSGRPID = 1). The study director is associated with the test facility. | | Rows 14-16: | Show that TSGRPID (TSGRPID=4) has been used to link the information on the testing guideline followed on this study (TSTGDNAM, TSTGDORG, TSTGDVER). | | | Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
key | TOBA-56 | Shows the study type for this study. | | Shows that this study includes a Neutral Red Uptake Assay. | | Rows 19-20: | Show that the species is human and the cell line is NHK in this study. |
|
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | TSSEQ | TSGRPID | TSPARMCD | TSPARM | TSVAL | TSVALNF |
|---|
| 1 | 123 | TS | 1 |
| GLPTYP | Good Laboratory Practice Type | FDA |
| | 2 | 123 | TS | 2 |
| GLPTYP | Good Laboratory Practice Type | OECD |
| | 3 | 123 | TS | 1 |
STSTDTC | Study Start Date | 2022-05-25STITLE
| STSTDTC | Study Start Date | 2022-05-25 |
| | 5 | 123 | TS | 1 |
| STITLE | Study Title | Determination of the in vitro genotoxicity potential using the in vitro Neutral Red Uptake assay |
5
| | 6 | 123 | TS | 1 |
| SNDIGVER | SEND Implementation Guide Version | TOBACCO IMPLEMENTATION GUIDE VERSION 1.0 |
6
| | 7 | 123 | TS | 1 |
| SNDCTVER | SEND Controlled Terminology Version | SEND Terminology 2021-09-30 |
7 Organization8
| | 9 | 123 | TS | 1 |
| APREFID | Applicant Study Reference ID |
| NOT APPLICABLE |
9| 10 | 123 | TS | 1 | 1 | TSTFNAM | Test Facility Name | Example Test Lab Name |
10
| | 11 | 123 | TS | 1 | 1 | TSTFLOC | Test Facility Location | 10 Somewhere Street, Montgomery, AL 10000 |
11
| | 12 | 123 | TS | 1 | 1 | TFCNTRY | Test Facility Country | USA |
12
| | 13 | 123 | TS | 1 | 1 | STDIR | Study Director | Dr. R. Smith |
13 | 123 | TS | 1 | GLPFL | GLP Flag | Y |
| | 14 | 123 | TS | 1 | 4 | TSTGDNAM | Testing Guideline Name | Publication No. 07-4519 |
| | 15 | 123 | TS | 1 | 4 | TSTGDORG | Testing Guideline Organization | NIH |
| | 16 | 123 | TS | 1 | 4 | TSTGDVER | Testing Guideline Version | 2006-11 |
| | 17 | 123 | TS | 1 |
| SSTYP | Study Type | GENOTOXICITY IN VITRO |
| | 18 | 123 | TS | 1 |
| GNTXAID | Genetic Toxicology Assay Identifier | NRU |
| | 19 | 123 | TS | 1 |
| SPECIES | Species | HUMAN |
| | 20 | 123 | TS | 1 |
| CELLLN | Cell Line | NHK |
|
|
|
| Dataset wrap |
|---|
| Rowcaps |
|---|
| Rows 1-12: | Show the test conditions for the |
|
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-279 |
|---|
|
| Rowcaps |
|---|
| Rows 1-12: | Show the test conditions for the set with a short name or SETCD value of NRU. The applicant chose this value to represent test conditions for the entire assay. | | Rows 13-2031: | Show the test conditions for the set with a short name or SETCD value of CSC-50b. The applicant chose this value to represent plate number 1, well row A, well column 3, with a concentration of 50µg/mLof cigarette smoke condensate as shown in the report table for study 123. The value for Cell Line (CELLLN) is not applicable because the well is a media-only well, having no NHK cells. | Rows 2132-2850: | Show the test conditions for the set with a short name or SETCD value of CSC-50. The applicant chose this value to represent plate number 1, well rows B-G, well column 3 and plate number 2, well rows A-H, well column 3. These all have the concentration of 50µg/mLof cigarette smoke condensate as shown in the report table for study 123. | | Rows 2951-3669: | Show the test conditions for the set with a short name or SETCD value of SLS-110. The applicant chose this value to represent plate number 1, well rows B-G, well column 10, and plate number 2, well rows A-H, well column 10. These all have the concentration of 110µg/mLof sodium laurel sulfate as shown in the report table for study 123. |
|
| Dataset2 |
|---|
Row| ROW | STUDYID | DOMAIN | SETCD | SET | TXSEQ | TXPARMCD | TXPARM | TXVAL |
|---|
| 1 | 123 | TX | NRU | NRU_ASSAY | 1 | IVTDMIN | In vitro Treatment Duration Minimum | 47.5 | | 2 | 123 | TX | NRU | NRU_ASSAY | 2 | IVTDTRG | In vitro Treatment Duration Target | 48 | | 3 | 123 | TX | NRU | NRU_ASSAY | 3 | IVTDMAX | In vitro Treatment Duration Maximum | 48.5 | | 4 | 123 | TX | NRU | NRU_ASSAY | 4 | IVTDU | In vitro Treatment Duration Unit | HOURS | | 5 | 123 | TX | NRU | NRU_ASSAY | 5 | INCBTMP | Incubation Temperature | 37 | | 6 | 123 | TX | NRU | NRU_ASSAY | 6 | INCBTMPU | Incubation Temperature Unit | C | | 7 | 123 | TX | NRU | NRU_ASSAY | 7 | SWAVENM | Spectrophotometer Wavelength | 540 | | 8 | 123 | TX | NRU | NRU_ASSAY | 8 | ATMRHP | Atmospheric Relative Humidity Percent | 90 | | 9 | 123 | TX | NRU | NRU_ASSAY | 9 | ATMCO2P | Atmospheric CO2 Percent | 5 | | 10 | 123 | TX | NRU | NRU_ASSAY | 10 | SPDEVID | applicant defined device identifier | PUFFMASTER3k | | 11 | 123 | TX | NRU | NRU_ASSAY | 11 | SMKRGM | Smoking Regimen | MEDIUM INTENSITY REGIMEN | | 12 | 123 | TX | NRU | NRU_ASSAY | 12 | SPTOBID | Applicant-defined tobacco identifier | CIG01a | | 13 | 123 | TX | CSC-50b | CSC-50-blank | 13 |
PSETCD | Parent Set Code | | IVTDMIN | In vitro Treatment Duration Minimum | 47.5 |
NRU | | 14 | 123 | TX | CSC-50b | CSC-50-blank | 14 |
EXPTYP | Exposure Type | | IVTDTRG | In vitro Treatment Duration Target | 48 |
Air Liquid Interface | | 15 | 123 | TX | CSC-50b | CSC-50-blank | 15 |
SAMTYP | Sample Type | | IVTDMAX | In vitro Treatment Duration Maximum | 48.5 |
Whole Smoke Conditioned Media | | 16 | 123 | TX | CSC-50b | CSC-50-blank | 16 |
ITVNAM | Name of the Intervention Article | | IVTDU | In vitro Treatment Duration Unit | HOURS |
Tobacco ProdA | | 17 | 123 | TX | CSC-50b | CSC-50-blank | 17 |
ITVTYPE | Intervention Article Type | | INCBTMP | Incubation Temperature | 37 |
PRODUCT | | 18 | 123 | TX | CSC-50b | CSC-50-blank | 18 |
ITVCONC | Intervention Article Concentration | | INCBTMPU | Incubation Temperature Unit | C |
50 | | 19 | 123 | TX | CSC-50b | CSC-50-blank | 19 |
ITVCONCU | Intervention Article Concentration Unit | | SWAVENM | Spectrophotometer Wavelength | 540 |
ug/ml | | 20 | 123 | TX | CSC-50b | CSC-50-blank | 20 |
CELLLN | Cell Line | | ATMRHP | Atmospheric Relative Humidity Percent | 90 |
NOT APPLICABLE50PSETCD | Parent Set Code | | ATMCO2P | Atmospheric CO2 Percent | 5 |
NRU50EXPTYP | Exposure Type | | SPDEVID | applicant defined device identifier | PUFFMASTER3k |
Air Liquid Interface50SAMTYPSample Type | | Smoking Regimen | MEDIUM INTENSITY REGIMEN |
Whole Smoke Conditioned Media50ITVNAM | Intervention Article Name | | SPTOBID | Applicant-defined tobacco identifier | CIG01a |
Tobacco ProdA50ITVTYPEIntervention Article PRODUCT| Air Liquid Interface | | 26 | 123 | TX | CSC- |
50ITVCONC | Intervention Article Concentration | | SAMTYP | Sample Type | Whole Smoke Conditioned Media |
5050ITVCONCU| ITVNAM | Name of the Intervention Article |
Concentration Unitug/ml50CELLLN | Cell Line | | ITVTYPE | Intervention Article Type | PRODUCT |
NHKSLS110SLS110PSETCD | Parent Set Code | | ITVCONC | Intervention Article Concentration | 50 |
NRUSLS110SLS110EXPTYP | Exposure Type | | ITVCONCU | Intervention Article Concentration Unit | ug/ml |
Air Liquid InterfaceSLS110SLS110SAMTYPSample Type | LiquidSLS110SLS110ITVNAM | Intervention Article Name | | IVTDMIN | In vitro Treatment Duration Minimum | 47.5 |
Sodium Laurel SulfateSLS110SLS110ITVTYPE | Intervention Article Type | | IVTDTRG | In vitro Treatment Duration Target | 48 |
POSITIVE CONTROLSLS110SLS110ITVCONC | Intervention Article Concentration | | IVTDMAX | In vitro Treatment Duration Maximum | 48.5 |
110SLS110SLS110ITVCONCU | Intervention Article Concentration Unit | | IVTDU | In vitro Treatment Duration Unit | HOURS |
ug/mlSLS110SLS110CELLLNCell LineNHK| 37 | | 37 | 123 | TX | CSC-50 | CSC-50 | 37 | INCBTMPU | Incubation Temperature Unit | C | | 38 | 123 | TX | CSC-50 | CSC-50 | 38 | SWAVENM | Spectrophotometer Wavelength | 540 | | 39 | 123 | TX | CSC-50 | CSC-50 | 39 | ATMRHP | Atmospheric Relative Humidity Percent | 90 | | 40 | 123 | TX | CSC-50 | CSC-50 | 40 | ATMCO2P | Atmospheric CO2 Percent | 5 | | 41 | 123 | TX | CSC-50 | CSC-50 | 41 | SPDEVID | applicant defined device identifier | PUFFMASTER3k | | 42 | 123 | TX | CSC-50 | CSC-50 | 42 | SMKRGM | Smoking Regimen | MEDIUM INTENSITY REGIMEN | | 43 | 123 | TX | CSC-50 | CSC-50 | 43 | SPTOBID | Applicant-defined tobacco identifier | CIG01a | | 44 | 123 | TX | CSC-50 | CSC-50 | 44 | EXPTYP | Exposure Type | Air Liquid Interface | | 45 | 123 | TX | CSC-50 | CSC-50 | 45 | SAMTYP | Sample Type | Whole Smoke Conditioned Media | | 46 | 123 | TX | CSC-50 | CSC-50 | 46 | ITVNAM | Intervention Article Name | Tobacco ProdA | | 47 | 123 | TX | CSC-50 | CSC-50 | 47 | ITVTYPE | Intervention Article Type | PRODUCT | | 48 | 123 | TX | CSC-50 | CSC-50 | 48 | ITVCONC | Intervention Article Concentration | 50 | | 49 | 123 | TX | CSC-50 | CSC-50 | 49 | ITVCONCU | Intervention Article Concentration Unit | ug/ml | | 50 | 123 | TX | CSC-50 | CSC-50 | 50 | CELLLN | Cell Line | NHK | | 51 | 123 | TX | SLS-110 | SLS-110 | 51 | IVTDMIN | In vitro Treatment Duration Minimum | 47.5 | | 52 | 123 | TX | SLS-110 | SLS-110 | 52 | IVTDTRG | In vitro Treatment Duration Target | 48 | | 53 | 123 | TX | SLS-110 | SLS-110 | 53 | IVTDMAX | In vitro Treatment Duration Maximum | 48.5 | | 54 | 123 | TX | SLS-110 | SLS-110 | 54 | IVTDU | In vitro Treatment Duration Unit | HOURS | | 55 | 123 | TX | SLS-110 | SLS-110 | 55 | INCBTMP | Incubation Temperature | 37 | | 56 | 123 | TX | SLS-110 | SLS-110 | 56 | INCBTMPU | Incubation Temperature Unit | C | | 57 | 123 | TX | SLS-110 | SLS-110 | 57 | SWAVENM | Spectrophotometer Wavelength | 540 | | 58 | 123 | TX | SLS-110 | SLS-110 | 58 | ATMRHP | Atmospheric Relative Humidity Percent | 90 | | 59 | 123 | TX | SLS-110 | SLS-110 | 59 | ATMCO2P | Atmospheric CO2 Percent | 5 | | 60 | 123 | TX | SLS-110 | SLS-110 | 60 | SPDEVID | applicant defined device identifier | PUFFMASTER3k | | 61 | 123 | TX | SLS-110 | SLS-110 | 61 | SMKRGM | Smoking Regimen | MEDIUM INTENSITY REGIMEN | | 62 | 123 | TX | SLS-110 | SLS-110 | 62 | SPTOBID | Applicant-defined tobacco identifier | CIG01a | | 63 | 123 | TX | SLS-110 | SLS-110 | 63 | EXPTYP | Exposure Type | Air Liquid Interface | | 64 | 123 | TX | SLS-110 | SLS-110 | 64 | SAMTYP | Sample Type | Liquid | | 65 | 123 | TX | SLS-110 | SLS-110 | 65 | ITVNAM | Intervention Article Name | Sodium Laurel Sulfate | | 66 | 123 | TX | SLS-110 | SLS-110 | 66 | ITVTYPE | Intervention Article Type | POSITIVE CONTROL | | 67 | 123 | TX | SLS-110 | SLS-110 | 67 | ITVCONC | Intervention Article Concentration | | | 68 | 123 | TX | SLS-110 | SLS-110 | 68 | ITVCONCU | Intervention Article Concentration Unit | ug/ml | | 69 | 123 | TX | SLS-110 | SLS-110 | 69 | CELLLN | Cell Line | NHK |
|
|
| Dataset wrap |
|---|
|
The applicant chose to define the REFID values to indicate the Plate, the Column, and the Row of the wells of the 96-well plate in use, such that the well on plate 2, column 10, row G would assigned a REFID of 2-10-G. |
| Dataset wrap |
|---|
|
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-280 |
|---|
|
| Rowcaps |
|---|
| Row 1: | Shows the REFID of 123NRU that indicates the entire assay. | | Rows 2, 5, 8, 9:-4: | Show the REFIDs at the second level, all within the parent assay of 123NRU (REFID values of 1-3b, 1-3, 1-10, 2-10) which have LVLDESC of OBSERVATIONAL UNITSUMMARY. If this study had recorded summary statistics for an entire trial set (e.g., across both plates for the same dose level), there would be an additional REFID for the trial set (with a LVLDESC of TRIAL SET). | | Rows 3-4, 6-7, 10-11: | Show REFID values that the applicant chose, in this case, to represent the plate number (1 or 2), column (1 - 12), and row (A-G) of the 96-well plates. | | (e.g., across both plates for the same dose level), there would be an additional REFID for the trial set (with a LVLDESC of TRIAL SET). | | Rows 5-6Rows 3-4: | Show the REFIDs 1-3-A and 1-3-H that indicate two experimental units that are also observational units within the SETCD of CSC-50b that have the parent trial set of 1-3bREFID of 123NRU. | | Rows 67-78: | Show the REFIDs 1-3-B and 1-3-C that indicate two experimental units that are also observational units within the parent trial set SETCD of CSC-50 that have the parent REFID of 1-3. | | Row 109: | Shows the REFID of 1-10-G that indicates the experimental unit that is also an observational unit within the parent trial set SETCD of SLS-110 that has the parent REFID of 1-10. | | Row 1110: | Shows the REFID of 2-10-G that indicates the experimental unit that is also an observational unit within the SETCD of SLS-110 that has the parent trial set REFID of 2-10. |
|
| Dataset2 |
|---|
| | Row | STUDYID | SETCD | REFID | PARENT | LEVEL | LVLDESC |
|---|
| 1 | 123 | | 123NRU |
| 1 | ASSAY | | 2 | 123 | CSC- |
50b3b UNITCSC-50b | 1-3-A3b3EXPERIMENTAL UNIT| OBSERVATIONAL SUMMARY | | 4 | 123 |
CSC50b13-H1-3b | 3 | EXPERIMENTAL UNIT| 10 | 123NRU | 2 | OBSERVATIONAL SUMMARY | | 5 | 123 | CSC- |
5050b | 1-3-A | 123NRU | 2 | EXPERIMENTAL UNIT/OBSERVATIONAL UNIT | | 6 | 123 | CSC- |
50B1-33| 2 | EXPERIMENTAL UNIT/OBSERVATIONAL UNIT | | 7 | 123 | CSC-50 | 1-3- |
C8 | 123 | SLS-110 | 1-10 | 123NRU | 2 | 9SLS110210123NRU2| 3 | EXPERIMENTAL UNIT/OBSERVATIONAL UNIT |
10| 9 | 123 | SLS-110 | 1-10-G | 1-10 | 3 | EXPERIMENTAL UNIT/OBSERVATIONAL UNIT |
11| 10 | 123 | SLS-110 | 2-10-G | 2-10 | 3 | EXPERIMENTAL UNIT/OBSERVATIONAL UNIT |
|
|
| Dataset wrap |
|---|
|
Certain data (Absorbance Reading and Background Corrected Absorbance Reading | Rowcaps |
|---|
|
| Rows 1-3: | Show the experimental unit data for GTREFID 1-3-B. |
Rows 1-2, 4-5, 10-11, 16-17: | These data (absorbance reading and background absorbance reading) are not shown in the sample report table above but are included here for completeness of the NRU assay.
| Rowcaps |
|---|
| Rows 1-3: | Show the experimental unit data for GTREFID 1-3-B. | | Rows 4-6: | Show the experimental unit data for GTREFID 1-3-C. | | Rows 7-9: | Show the data for the entire trial set, GTREFID=1-3. | | Rows 10-12: | Show the experimental unit data for GTREFID 1-10-G | | Rows 13-15: | Show the data for the entire trial set, GTREFID=1-10 | | Rows 16-18: | Show the experimental unit data for GTREFID 2-10-G. | | Rows 19-21: | Show the data for the entire trial set, GTREFID=2-10 | | Row 22: | Shows the data for the entire assay, GTREFID=123NRU. |
| Jira |
|---|
|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
key | TOBA-592
| Dataset2 |
|---|
| Row | STUDYID | DOMAIN | GTSEQ | GTREFID | GTTESTCD | GTTEST | GTORRES | GTORRESU | GTCOLSRT | GTSTRESC | GTSTRESN | GTSTRESU |
|---|
| 1 | 123 | GT | 1 | 1-3-B | ABSORB | Absorbance Reading | 1.7 |
|
| 1.7 | 1.7 |
| | 2 | 123 | GT | 2 | 1-3-B | BKCABS | Background Corrected Absorbance Reading | 1.6 |
|
| 1.6 | 1.6 |
| | 3 | 123 | GT | 3 | 1-3-B | RELABS | Relative Absorbance Reading | 77.7 |
%% |
| | 4 | 123 | GT | 4 | 1-3-C | ABSORB | Absorbance Reading | 1.8 |
|
| 1.8 | 1.8 |
| | 5 | 123 | GT | 5 | 1-3-C | BKCABS | Background Corrected Absorbance Reading | 1.7 |
|
| 1.7 | 1.7 |
| | 6 | 123 | GT | 6 | 1-3-C | RELABS | Relative Absorbance Reading | 77.4 |
|
| 77.4 | 77.4 |
| | 7 | 123 | GT | 7 | 1-3 | RELABS | Relative Absorbance Reading | 78.2 | % | MEAN | 78.2 | 78.2 | % | | 8 | 123 | GT | 8 | 1-3 | RELABS | Relative Absorbance Reading | 2.9 | % | STANDARD DEVIATION | 2.9 | 2.9 | % | | 9 | 123 | GT | 9 | 1-3 | RELABS | Relative Absorbance Reading | 3.6 |
| COEFFICIENT OF VARIANCE | 3.6 | 3.6 |
| | 10 | 123 | GT | 10 | 1-10-G | ABSORB | Absorbance Reading | 0.7 |
|
| 0.7 | 0.7 |
| |
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
| key | TOBA-598 |
|---|
| | 123 | GT | 11 | 1-10-G | BKCABS | Background Corrected Absorbance Reading | 0.6 |
|
| 0.6 | 0.6 |
| | 12 | 123 | GT | 12 | 1-10-G | RELABS | Relative Absorbance Reading | 8.57 |
|
| 8.57 | 8.57 |
| | 13 | 123 | GT | 13 | 1-10 | RELABS | Relative Absorbance Reading | 8.94 | % | MEAN | 8.94 | 8.94 |
| | 14 | 123 | GT | 14 | 1-10 | RELABS | Relative Absorbance Reading | 2.72 | % | STANDARD DEVIATION | 2.72 | 2.72 |
| | 15 | 123 | GT | 15 | 1-10 | RELABS | Relative Absorbance Reading | 30.5 |
| COEFFICIENT OF VARIANCE | 30.5 | 30.5 |
| | 16 | 123 | GT | 16 | 2-10-G | ABSORB | Absorbance Reading | 0.9 |
|
|
|
|
| | 17 | 123 | GT | 17 | 2-10-G | BKCABS | Background Corrected Absorbance Reading | 0.8 |
|
|
|
|
| | 18 | 123 | GT | 18 | 2-10-G | RELABS | Relative Absorbance Reading | 6.30 |
|
| 6.30 | 6.30 |
| | 19 | 123 | GT | 19 | 2-10 | RELABS | Relative Absorbance Reading | 5.91 | % | MEAN | 5.91 | 5.91 |
| | 20 | 123 | GT | 20 | 2-10 | RELABS | Relative Absorbance Reading | 0.83 | % | STANDARD DEVIATION | 0.83 | 0.83 |
| | 21 | 123 | GT | 21 | 2-10 | RELABS | Relative Absorbance Reading | 14.1 |
| COEFFICIENT OF VARIANCE | 14.1 | 14.1 |
| | 22 | 123 | GT | 22 | 123NRU | |
| Jira |
|---|
| showSummary | false |
|---|
| server | Issue Tracker (JIRA) |
|---|
| serverId | 85506ce4-3cb3-3d91-85ee-f633aaaf4a45 |
|---|
key | TOBA-132 | Effective Concentration of 50 Percent Cytotoxicity | 123 | ug/ml |
| 123 | 123 | ug/ml |
|